Back to results
US 2002/0177580 A1Published application
Means and method for hormonal contraception
OwnerAgatha Antonia Magdalena Van Beek, Herman Jan Tijmen Coelingh Benninkinventors
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
OwnerAgatha Antonia Magdalena Van Beek, Herman Jan Tijmen Coelingh Benninkinventors
Estimating the term…
A contraceptive method comprises the administration of a hormone composition in an amount effective to inhibit ovulation. More specifically the invention relates to the use of a hormone composition in the manufacture of a kit containing a plurality of dosage units for use in a contraceptive method, which method comprises administering a sequence of the dosage units to a female of childbearing capability so as to provide the hormone composition in an amount which is effective to inhibit ovulation, wherein the hormone composition is dydrogesterone component or a combination of estrogen and dydrogesterone component. Another embodiment concerns an oral contraceptive kit comprising from 20-35 daily oral dosage units, wherein 10-35 units contain a combination of estrogen in an amount equivalent to at least 2 μg ethinyl estradiol and dydrogesterone component in an amount equivalent to at least 2 mg dydrogesterone, 0-25 units contain estrogen in an amount equivalent to at lease 2 μg ethinyl estradiol and no progestogen, and 0-8 units contain no progestogen and no estrogen.
A contraceptive method which uses a plurality of dosage units containing a hormone composition, which method comprises administering a sequence of said dosage units to a female of childbearing capability so as to provide the hormone composition in an amount which is effective to inhibit ovulation, wherein the hormone composition is dydrogesterone component or a combination of estrogen and dydrogesterone component.
Method according to claim, 1, wherein the hormone composition is dydrogesterone component and wherein the dosage units contain the dydrogesterone component in an amount equivalent to at least 2 mg dydrogesterone, preferably 3-50 mg dydrogesterone.
An oral contraceptive kit comprising from 20-35 daily oral dosage units, wherein 10-35 units contain a combination of estrogen in an amount equivalent to at least 2 μg ethinyl estradiol and dydrogesterone component in an amount equivalent to at least 2 mg dydrogesterone, 0-25 units contain estrogen in an amount equivalent to at least 2 μg ethinyl estradiol and no progestogen, and 0-8 units contain no progestogen and no estrogen.
Dependencies are inferred from the claim text.